Ferring Pharmaceuticals |
55566980010 |
REBYOTA (Fecal microbiota, live -jslm) |
Brand |
FDA |
2023-01-23 |
9000.0000 |
None |
1 |
4500 |
1 |
1 |
None |
None |
None |
None |
REBYOTA was not acquired. Comment regarding estimated patients: Ferring estimates the annual patient estimate to be in the range of 4,000-5,000. This patient estimate is based on a national annual projection for the product based on disease state and indication. We do not have estimates for individual states at this time. |
None |
Ferring Pharmaceuticals |
55566105001 |
ADSTILADRIN® (nadofaragene firadenovec-vncg), 4 x 80 mL Intravesical Suspension, Vial |
Brand |
FDA |
2023-09-05 |
60000.0000 |
None |
1 |
8500 |
1 |
1 |
None |
None |
None |
None |
Adstiladrin was not acquired. Comment regarding estimated patients: Based on current supply constraints, Ferring is capable of supplying Adstiladrin to approximately 400 patients in 2023 and 900 patients in 2024. Overall market when supply constraint is lifted in 2025 will be 8-9k patients per year. This patient estimate is based on a national annual projection for the product based on disease state and indication. We do not have estimates for individual states at this time. |
https://reports.siera.hcai.ca.gov/api/report/drug-pricing/attachment?id=710 |
Florida Pharmaceutical Products, LLC |
71921017706 |
Purple oval shaped, biconvex bevel edged film-coated tablets, debossed with "A" on one side and "500" on the other side |
Generic |
FDA |
2023-05-08 |
1800.0000 |
Since this ANDA is already generic in the US market and there are other generics available to pharmacies, there is no additional marketing plan required. Our general marketing plan for generic pharmaceuticals is to speak to buyers at wholesale distributors and retail pharmacy chains. Our pricing per bottle will be in alignment with average net pricing currently available. There is no intention to speak to prescribers. |
None |
24000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219037110 |
Stimufend Subcutaneous Solution Prefilled Syringe 6 MG/0.6ML Package Size 0.6 Package Quantity 1 |
Brand |
FDA |
2023-02-08 |
4175.0000 |
None |
1 |
1500 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219040303 |
Zinc Sulfate Intravenous Solution 3 MG/ML Package Size 10 Package Quantity 25 |
Generic |
FDA |
2023-02-15 |
1050.0000 |
None |
None |
83 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219040505 |
Zinc Sulfate Intravenous Solution 5 MG/ML Package Size 5 Package Quantity 25 |
Generic |
FDA |
2023-02-15 |
875.0000 |
None |
None |
3900 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219056420 |
Mitomycin intravenous solution reconstituted 5 MG 1 Vial |
Generic |
FDA |
2023-03-01 |
243.2700 |
None- generic product. |
None |
100 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219056620 |
mitoMYcin Intravenous Solution Reconstituted 20 MG Package Size 1 Package Quantity 1 |
Generic |
FDA |
2023-03-07 |
631.9800 |
None- generic product. $0 – There was no budgeted or actual spending for direct-to-consumer or physician marketing. |
None |
100 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219056800 |
mitoMYcin Intravenous Solution Reconstituted 40 MG Package Size 1 Package Quantity 1 |
Generic |
FDA |
2023-03-28 |
1263.9600 |
None- generic product. $0 – There was no budgeted or actual spending for direct-to-consumer or physician marketing. |
None |
100 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
63323057905 |
Sincalide Injection Solution Reconstituted 5 MCG Package Size 1 Package Quantity 10 |
Brand |
FDA |
2023-06-20 |
1241.3000 |
None |
1 |
800000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219055438 |
Idacio for Crohns Disease/UC Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 3 |
Brand |
FDA |
2023-07-01 |
19729.4700 |
None |
1 |
600000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219055428 |
Idacio for Plaque Psoriasis Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 2 |
Brand |
FDA |
2023-07-01 |
13152.9800 |
None |
1 |
600000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219055408 |
Idacio Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 1 |
Brand |
FDA |
2023-07-01 |
6576.4900 |
None |
1 |
600000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219055618 |
Idacio Subcutaneous Prefilled Syringe Kit 40 MG/0.8ML Package Size 1 Package Quantity 1 |
Brand |
FDA |
2023-07-01 |
6576.4900 |
None |
1 |
600000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219002805 |
Ganirelix Acetate Subcutaneous Solution Prefilled Syringe 250 MCG/0.5ML |
Generic |
FDA |
2023-07-07 |
216.4500 |
None |
1 |
230000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219025810 |
Cardioplegic Perfusion Solution Package Size 1000 ML Package Quantity 10 |
Generic |
FDA |
2023-07-18 |
495.1000 |
None |
None |
21600 |
None |
None |
None |
None |
None |
None |
WAC is 495.10 with a package quantity of 10 bags however a 30 day course of therapy can range from 2-20 bags. Therefore if 20 bags are needed in a 30 day course of therapy the WAC would be $990.20 |
None |
Fresenius Kabi USA LLC |
65219028412 |
Plerixafor Subcutaneous Solution 24 MG/1.2ML Package Size 1.2 ML Package Quantity 1 |
Generic |
FDA |
2023-07-24 |
2990.0000 |
None |
1 |
12000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219057901 |
Carboprost Tromethamine Intramuscular Solution 250 MCG/ML 10 Vials |
Generic |
FDA |
2023-07-25 |
1320.0000 |
None |
1 |
20000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219028110 |
Gadobutrol Intravenous Solution Package Size 10 ML Package Quantity 20 |
Generic |
FDA |
2023-07-31 |
1162.0000 |
None |
1 |
13200000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219028107 |
Gadobutrol Intravenous Solution Package Size 7.5 ML Package Quantity 20 |
Generic |
FDA |
2023-07-31 |
871.6000 |
None |
1 |
13200000 |
None |
None |
None |
None |
None |
None |
None |
None |
Fresenius Kabi USA LLC |
65219028115 |
Gadobutrol Intravenous Solution Package Size 15 ML Package Quantity 20 |
Generic |
FDA |
2023-07-31 |
1743.0000 |
None |
1 |
13200000 |
None |
None |
None |
None |
None |
None |
None |
None |